AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024
/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the presentation of new respiratory data at the American Thoracic Society (ATS) 2024 International...
Source: prnewswire.com
Associated Vasculitis News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Associated Vasculitis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Associated Vasculitis Today - Breaking & Trending Today
Q32 Bio concludes merger deal with Homology Medicines
Clinical stage biotechnology company Q32 Bio has announced the conclusion of its merger with Homology Medicines, for an undisclosed sum.
Q32 Bio Announces Publication of Preclinical Data in Molecular Therapy Demonstrating the Therapeutic Potential of Tissue-Targeted Complement Inhibitor ADX-097 for Complement-Mediated Diseases
/PRNewswire/ -- Q32 Bio Inc., a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, today announced the...
Source: prnewswire.com
Q32 Bio and Homology Medicines Announce Merger Agreement
--The combined company will operate as Q32 Bio Inc., advancing the development of Q32 Bio's two clinical development candidates, bempikibart in Phase 2 for the treatment of atopic dermatitis and...
Source: marketscreener.com
Avacopan Improves Kidney Health in ANCA-Associated Vasculitis with eGFRs Less than 20
Data from patients with eGFR of 20 mL/min/1.73m2 or less from the ADVOCATE trial provide new insight into the effects of avacopan use in patients with lower baseline eGFRs.
Source: hcplive.com